It is estimated by the Alzheimer Society of Canada that about 564,000 Canadians will suffer from dementia in 2016. Medical professionals will diagnose an additional 25,000 cases every single year, and by 2031 it is believed the number of patients suffering from dementia will rise to 937,000. Dementia is a huge problem not only in Canada, but across the globe. Unfortunately, there haven’t been any significant scientific breakthroughs that could slow the progress of the disease—until now. If you’re a student enrolled in a pharmaceutical program, you may understand the groundbreaking impact this scientific breakthrough could bring to dementia patients… READ MORE »
The medical landscape has undergone a dramatic shift recently, due in large part to massive technological advances that have improved the levels of precision and treatment that were previously being used. This constant growth in technological capabilities has allowed pharmaceutical companies to constantly innovate, test new products, and market better treatments for their patients. What this means is that there are always new products that need to undergo extensive quality control and assurance in order to be marketed and sold to the masses. This steady stream of work makes doing pharmaceutical quality assurance an attractive career option. If you’re interested.. READ MORE »
